Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Inhalte:

  • => Welche Forschungsthemen werden an der Medizinischen Universität bearbeitet?.
  • => Wer ist daran beteiligt und welche Methoden werden angewandt?.
  • => Welche Fördergeber unterstützen welche Projekte?.
  • => Wo werden Forschungsergebnisse publiziert?.

Facts and Figures: 2.543 Forscher*innenprofile (davon 892 mit ORCID-ID), 7.195 Forschungsprojekte, 141.107 Publikationen, Posters und Vorträge, 56.292 Volltextlinks (davon Volltext frei zugänglich: > 24.277 (Open Access) )

Aktuelle Zitierungen im Web of Science: 1.566.802, davon 3.103 citation classics (>=100 Zitierungen) Summe Altmetrics Score: 217.415

Aktuell durch Fördergeber bewilligte Forschungsprojekte:

ELPHI: Bioelektronische Implantate für steuerbare Chemoimmunotherapie
Projektleitung: Waldherr Linda
Laufzeit: 01.01.2023 - 31.12.2026
Geldgeber: BioTechMed-Graz

Diagnostic Tool for Sepsis Detection
Projektleitung: Krause Robert
Laufzeit: 01.04.2023 - 31.12.2023
Geldgeber: acib GmbH
Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review)

> Weitere neue Projekte

Die aktuellsten Publikationen in "Top-Journalen" (Top 20 % Impact Ranking):


07.06.2023:

Agarwal, B; Cañizares, RB; Saliba, F; Ballester, MP; Tomescu, DR; Martin, D; Stadlbauer, V; Wright, G; Sheikh, M; Morgan, C; Alzola, C; Lavin, P; Green, D; Kumar, R; Sacleux, SC; Schilcher, G; Koball, S; Tudor, A; Minten, J; Domenech, G; Aragones, JJ; Oettl, K; Paar, M; Waterstradt, K; Bode-Boger, SM; Ibáñez-Samaniego, L; Gander, A; Stange, J; Lamprecht, G; Sanchez, M; Mookerjee, RP; Davenport, A; Davies, N; Pavesi, M; Andreola, F; Albillos, A; Cordingley, J; Schmidt, H; Carbonell-Asins, JA; Arroyo, V; Fernandez, J; Mitzner, S; Jalan, R Randomized-controlled trial of the DIALIVE liver dialysis device vs. standard of care in patients with acute-on-chronic liver failure.
J Hepatol. 2023; Doi: 10.1016/j.jhep.2023.03.013
PubMed FullText FullText_MUG

 

05.06.2023:

Chalhoub, G; Jamnik, A; Pajed, L; Kolleritsch, S; Hois, V; Bagaric, A; Prem, D; Tilp, A; Kolb, D; Wolinski, H; Taschler, U; Zullig, T; Rechberger, GN; Fuchs, C; Trauner, M; Schoiswohl, G; Haemmerle, G Carboxylesterase 2a deletion provokes hepatic steatosis and insulin resistance in mice involving impaired diacylglycerol and lysophosphatidylcholine catabolism
MOL METAB. 2023; 72: 101725 Doi: 10.1016/j.molmet.2023.101725 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

05.06.2023:

Frohlich, E; Loizou, GD Editorial: 3Rs-Strategies for reduction and refinement of animal studies
FRONT PHARMACOL. 2023; 14: 1200965 Doi: 10.3389/fphar.2023.1200965 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

05.06.2023:

Marx, N; Wanner, C; Jankowski, J; Marz, W; Krane, V; Genser, B Recurrent cardiovascular events in patients with type 2 diabetes and haemodialysis: analysis from the 4D Study
CLIN KIDNEY J. 2023; Doi: 10.1093/ckj/sfad029
Web of Science FullText FullText_MUG

 

05.06.2023:

L'Orphelin, JM; Cassecuel, J; Kandolf, L; Harwood, CA; Tookey, P; Junejo, MH; Hogan, S; Lebbe, C; Appalla, Z; Kranke, TM; Pellacani, G; Cerasuolo, D; Dujovic, B; Del Marmol, V; Forschner, A; Garbe, C; Bataille, V; Ressler, JM; Sollena, P; Dompmartin, A; Peris, K; Dreno, B Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients-The European MelSkinTox study
J EUR ACAD DERMATOL. 2023; Doi: 10.1111/jdv.19112
Web of Science PubMed FullText FullText_MUG

 

05.06.2023:

Hegen, H; Berek, K; Bsteh, G; Auer, M; Altmann, P; Di Pauli, F; Grams, A; Milosavljevic, D; Ponleitner, M; Poskaite, P; Schnabl, C; Wurth, S; Zinganell, A; Berger, T; Walde, J; Deisenhammer, F Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort study
EBIOMEDICINE. 2023; 91: 1-9. Doi: 10.1016/j.ebiom.2023.104573 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

05.06.2023:

Lara-Hernandez, A; Rienmuller, T; Juarez, I; Perez, M; Reyna, F; Baumgartner, D; Makarenko, VN; Bockeria, OL; Maksudov, M; Rienmuller, R; Baumgartner, C Deep Learning-Based Image Registration in Dynamic Myocardial Perfusion CT Imaging
IEEE T MED IMAGING. 2023; 42(3): 684-696. Doi: 10.1109/TMI.2022.3214380
Web of Science PubMed FullText FullText_MUG

 

05.06.2023:

Nijman, RG; Tan, CD; Hagedoorn, NN; Nieboer, D; Herberg, JA; Balode, A; von Both, U; Carrol, ED; Eleftheriou, I; Emonts, M; van der Flier, M; de Groot, R; Kohlmaier, B; Lim, E; Martinon-Torres, F; Pokorn, M; Strle, F; Tsolia, M; Yeung, S; Zachariasse, JM; Zavadska, D; Zenz, W; Levin, M; Vermont, CL; Moll, HA; Maconochie, IK Are children with prolonged fever at a higher risk for serious illness? A prospective observational study
ARCH DIS CHILD. 2023; Doi: 10.1136/archdischild-2023-325343
Web of Science PubMed FullText FullText_MUG

 

05.06.2023:

Sattler, S; Campos, Ramos, G; Ludewig, B; Rainer, PP Cardioimmunology: the new frontier!
EUR HEART J. 2023; Doi: 10.1093/eurheartj/ehad230
Web of Science PubMed FullText FullText_MUG

 

05.06.2023:

Patel, H; Sintou, A; Chowdhury, RA; Rothery, S; Iacob, AO; Prasad, S; Rainer, PP; Martinón-Torres, F; Sancho-Shimizu, V; Shimizu, C; Dummer, K; Tremoulet, AH; Burns, JC; Sattler, S; Levin, M, , DIAMONDS, consortium Evaluation of Autoantibody Binding to Cardiac Tissue in Multisystem Inflammatory Syndrome in Children and COVID-19 Vaccination-Induced Myocarditis.
JAMA Netw Open. 2023; 6(5): e2314291 Doi: 10.1001/jamanetworkopen.2023.14291 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

05.06.2023:

Hoenigl, M; Salmanton-García, J; Egger, M; Gangneux, JP; Bicanic, T; Arikan-Akdagli, S; Alastruey-Izquierdo, A; Klimko, N; Barac, A; Özenci, V; Meijer, EFJ; Khanna, N; Bassetti, M; Rautemaa-Richardson, R; Lagrou, K; Adam, KM; Akalin, EH; Akova, M; Arsic, Arsenijevic, V; Aujayeb, A; Blennow, O; Bretagne, S; Danion, F; Denis, B; de, Jonge, NA; Desoubeaux, G; Drgona, L; Erben, N; Gori, A; García, Rodríguez, J; Garcia-Vidal, C; Giacobbe, DR; Goodman, AL; Hamal, P; Hammarström, H; Toscano, C; Lanternier, F; Lass-Flörl, C; Lockhart, DEA; Longval, T; Loughlin, L; Matos, T; Mikulska, M; Narayanan, M; Martín-Pérez, S; Prattes, J; Rogers, B; Rahimli, L; Ruiz, M; Roilides, E; Samarkos, M; Scharmann, U; Sili, U; Sipahi, OR; Sivakova, A; Steinmann, J; Trauth, J; Turhan, O; Van, Praet, J; Vena, A; White, PL; Willinger, B; Tortorano, AM; Arendrup, MC; Koehler, P; Cornely, OA, , ECMM, Candida, III, Study, Group, , ECMM, Candida, III, Study, Group Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study.
Lancet Infect Dis. 2023; 23(6): 751-761. Doi: 10.1016/S1473-3099(22)00872-6
PubMed FullText FullText_MUG

 

> Weitere aktuelle Publikationen in Top-Journals

Distribution of Med Uni Graz affiliated publications by field-normalized Journal Impact Factor (JIFnorm)


Med Uni Graz publications1 were assigned quintiles according to the normalized2 Clarivate’s Journal Impact Factor of the journal at the time of publication.


Proportional Distribution: The color-coded columns show the distribution by JIFnorm-quintiles, while the left vertical axis indicates the proportion relative to the total articles published in a given year. The red line shows the total number of articles published each year (right vertical axis).


JIFnorm: Proportional Distribution


Example 1: Around 40% of the over 500 articles with Med Uni Graz affiliation published in 2019 had a normalized JIF > 0.8 (QU1).
Example 2: The proportion of articles published in journals with a normalized JIF < 0.4 (QU4 and QU5) has remained under 20% since 2010.

Absolute Impact: The sum of the normalized JIFs for all published articles in a given year, color-coded according to the respective quintile.


JIFnorm: Absolut Impact


1 This analysis considered only publications categorized as full papers/original articles.

2 IFnorm = (number of journals in WoS category - ranking of journal + 1) / number of journals in WoS category. An IFnorm of 0.8 means that 20% of the journals in this subject category have a higher IF than the respective journal. The highest possible IFnorm is 1, which means that this journal currently has the highest IF in this subject category.

© Med Uni Graz Impressum